Nalaganje...
Targeting colorectal cancer with human anti-EGFR monoclonocal antibodies: focus on panitumumab
The human anti-epidermal growth factor receptor (EGFR) monoclonal antibody, panitumumab, represents a significant advance in the treatment of colorectal cancer. The strategy to target this receptor is based on sound cancer biology demonstrating its essential role in colorectal carcinogenesis. Panitu...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2008
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2721355/ https://ncbi.nlm.nih.gov/pubmed/19707356 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|